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Correlation between perceived cardiovascular risk (CVR) by physicians
and real CVR is poorly known. Moreover, the underlying question of factors
associated to risk misevaluation, especially for patients at high CVR and that
could benefit of a lipid lowering therapy (LLT), remains unsolved.
 
Objective and methodology: 
 
This was an on-line non-interventional study
conducted on a sample of 619 general practitioners. The aim was to describe
the relation between physicians evaluated CVR and calculated CVR according
to risk’s scales. All consulting patients’ aged50 years old (YO) were included.
Physicians had to complete a questionnaire and to assess patient’s CVR on a
3 level scale (low, medium, and high). Framingham and SCORE (low
risk<2%, high risk5%) were calculated. 
 
Results: 
 
13446 patients were included (mean age: 67 YO, male: 48%,
LDLc1.3g/L: 46%, LLT: 36%, personal history of CV disease: 16%, smoker:
12%, high blood pressure (HBP): 52%, diabetes: 18%). 
Physicians evaluation mismatched with Framigham for 50% of the patients
and 27% were under-evaluated. Evaluation mismatched with SCORE for 53%
of the patients, 38% were under-evaluated. Within the 25% of the patients
having a Framingham score >20% and without a lipid lowering treatment,
70% was under evaluated by physicians. Within the 38% of the patients
having a SCORE calculation 5% and without a lipid lowering treatment, 78%
were under evaluated.
 
Conclusion: 
 
This study underlines the mismatch between GP perceived
CVR and calculated CVR, especially for high CVR patient. Males, patients
with treated HBP and with high LDL-c were at increased risk of CVR under-
evaluation.
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Objective:
 
 Human immunodeficiency virus (HIV)-infected patients
receiving combined active antiretroviral therapy (cART) are at higher risk of
cardiovascular disease, due in part to metabolic complications such as lipod-
ystrophy syndrome, insulin resistance, and dyslipidemia. Whether lipodys-
trophy and cART impact on the vasculature is debated. We investigated the
impact of lipodystrophy and protease inhibitors (PIs) on aortic stiffness.
 
Methods
 
:
 
 Aortic stiffness was evaluated using carotid–femoral pulse wave
velocity (PWV) in consecutive HIV-infected patients without a history of car-
diovascular disease referred to a cardiovascular clinic.
 
Results:
 
 175 patients were enrolled (mean age 48.2 ± 8.7 years; 89% men).
Eighty six per cent of patients were receiving cART. Dyslipidemia, tobacco,
and hypertension were the most prevalent cardiovascular risk factors (39%,
38%, and 31%, respectively). Seventy-nine (45%) HIV-infected patients had
lipodystrophy and 80 (46%) were on PIs. Aortic PWV was similar in patients
with or without lipodystrophy (9.7±1.9 vs 9.8±2.5 ms
 
-1
 
, respectively; 
 
P
 
 = 0.81)
and in patients on or not on PIs (9.8±2.6 vs 9.7±1.9 ms
 
-1
 
; 
 
P
 
 = 0.71). In
univariate analysis, aortic PWV was associated with increasing age, waist/hip
ratio, systolic and diastolic blood pressures, mean arterial and pulse pressures,
but not with presence of lipodystrophy, PIs, or specific factors related to HIV
infection. Linear regression analysis showed an association between aortic
PWV and age (= 0.49, 
 
P
 
 = 0.001) and systolic arterial pressure (= 0.21, 
 
P
 
 =
0.006).
 
Conclusions:
 
 Aortic stiffness is associated with traditional cardiovascular
risk factors, particularly ageing and blood pressure. Hypertension is becoming
an emerging complication in HIV-infected patients. 
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Objectifve: 
 
To determine the prevalence of hypertension in a cohort of
HIV-infected patients (
 
HIV+).
Methods: 
 
HIV+ patients were enrolled consecutively at ambulatory cardi-
ology consultation.  We evaluated :
cardiovascular risk factors,
office blood pressure,
 
Population risk is listed below
 
 Evaluated (%) Framingham (%) Score (%)
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Explanatory factors for under-evaluation in primary prevention according to 
SCORE:
 
 OR CI 95%
Treated HBP vs no HBP
 
2,55 2.04-3.19
 
Gender (male)
 
2,44 2,16-2,76
 
Higher LDLc
 
2,13 1,78-2,55
 
Smoker
 
1,82 1,52-2,19
 
Chronic inflammatory disease
 
1,19 1,00-1,42
 
Age
 
1,16 1,15-1,17
